These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 10448725)

  • 1. Pharmacy costs groups: a risk-adjuster for capitation payments based on the use of prescribed drugs.
    Lamers LM
    Med Care; 1999 Aug; 37(8):824-30. PubMed ID: 10448725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keep it simple? Predicting primary health care costs with clinical morbidity measures.
    Brilleman SL; Gravelle H; Hollinghurst S; Purdy S; Salisbury C; Windmeijer F
    J Health Econ; 2014 May; 35(100):109-22. PubMed ID: 24657375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating self-reported health measures in risk equalization through constrained regression.
    Withagen-Koster AA; van Kleef RC; Eijkenaar F
    Eur J Health Econ; 2020 Jun; 21(4):513-528. PubMed ID: 31916028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Adjustment in Health Insurance Markets: Do Not Overlook the "Real" Healthy.
    van Kleef RC; van Vliet RCJA; Oskam M
    Med Care; 2023 Dec; ():. PubMed ID: 38047754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jarvis's Adjuster.
    West J Med Surg; 1850 Sep; 6(3):272-273. PubMed ID: 38209652
    [No Abstract]   [Full Text] [Related]  

  • 6. Change in colorectal cancer (CRC) testing rates associated with the introduction of the first organized screening program in canton Uri, Switzerland: Evidence from insurance claims data analyses from 2010 to 2018.
    Bissig S; Syrogiannouli L; Schneider R; Tal K; Selby K; Del Giovane C; Bulliard JL; Senn O; Ducros C; Schmid CPR; Marbet U; Auer R
    Prev Med Rep; 2022 Aug; 28():101851. PubMed ID: 35757577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing risk adjustment estimation methods under data availability constraints.
    Iommi M; Bergquist S; Fiorentini G; Paolucci F
    Health Econ; 2022 Jul; 31(7):1368-1380. PubMed ID: 35384134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic prescription of antidepressant medication in patients with chronic kidney disease with and without kidney replacement therapy compared with matched controls in the Dutch general population.
    van Oosten MJM; Koning D; Logtenberg SJJ; Leegte MJH; Bilo HJG; Hemmelder MH; Jager KJ; Stel VS
    Clin Kidney J; 2022 Apr; 15(4):778-785. PubMed ID: 35371442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls.
    van Oosten MJM; Logtenberg SJJ; Hemmelder MH; Leegte MJH; Bilo HJG; Jager KJ; Stel VS
    Clin Kidney J; 2021 Dec; 14(12):2497-2523. PubMed ID: 34950462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dutch ICU survivors have more consultations with general practitioners before and after ICU admission compared to a matched control group from the general population.
    van Beusekom I; Bakhshi-Raiez F; de Keizer NF; van der Schaaf M; Termorshuizen F; Dongelmans DA
    PLoS One; 2019; 14(5):e0217225. PubMed ID: 31120959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a medication-based risk adjustment index to predict mortality among veterans dually-enrolled in VA and medicare.
    Radomski TR; Zhao X; Hanlon JT; Thorpe JM; Thorpe CT; Naples JG; Sileanu FE; Cashy JP; Hale JA; Mor MK; Hausmann LRM; Donohue JM; Suda KJ; Stroupe KT; Good CB; Fine MJ; Gellad WF
    Healthc (Amst); 2019 Dec; 7(4):. PubMed ID: 31031120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Comparison of Matching Methods Using Different Measures of Balance: Benefits and Risks Exemplified within a Study to Evaluate the Effects of German Disease Management Programs on Long-Term Outcomes of Patients with Type 2 Diabetes.
    Fullerton B; Pöhlmann B; Krohn R; Adams JL; Gerlach FM; Erler A
    Health Serv Res; 2016 Oct; 51(5):1960-80. PubMed ID: 26841379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool.
    Vivas-Consuelo D; Usó-Talamantes R; Guadalajara-Olmeda N; Trillo-Mata JL; Sancho-Mestre C; Buigues-Pastor L
    BMC Health Serv Res; 2014 Oct; 14():462. PubMed ID: 25331531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparison.
    Halfon P; Eggli Y; Decollogny A; Seker E
    BMC Health Serv Res; 2013 Oct; 13():453. PubMed ID: 24171918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predictive modeling approach to increasing the economic effectiveness of disease management programs.
    Bayerstadler A; Benstetter F; Heumann C; Winter F
    Health Care Manag Sci; 2014 Sep; 17(3):284-301. PubMed ID: 23780751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibration.
    Calderón-Larrañaga A; Abrams C; Poblador-Plou B; Weiner JP; Prados-Torres A
    BMC Health Serv Res; 2010 Jan; 10():22. PubMed ID: 20092654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of healthcare reform in the Netherlands.
    Rutten F
    Pharmacoeconomics; 2004; 22(2 Suppl 2):65-71. PubMed ID: 15660478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deductibles and health care expenditures: empirical estimates of price sensitivity based on administrative data.
    van Vliet RC
    Int J Health Care Finance Econ; 2004 Dec; 4(4):283-305. PubMed ID: 15467406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer price sensitivity and social health insurer choice in Germany and The Netherlands.
    Schut FT; Gress S; Wasem J
    Int J Health Care Finance Econ; 2003 Jun; 3(2):117-38. PubMed ID: 14626009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-mix adjusting performance measures in a veteran population: pharmacy- and diagnosis-based approaches.
    Liu CF; Sales AE; Sharp ND; Fishman P; Sloan KL; Todd-Stenberg J; Nichol WP; Rosen AK; Loveland S
    Health Serv Res; 2003 Oct; 38(5):1319-37. PubMed ID: 14596393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.